GLINE-2019-nCoV NAb (Neutralization Antibody) Test is a colloidal gold immunoassay (CGIA) for qualitative determination of the Neutralization antibodies from whole blood, serum or plasma. This assay can detect neutralization antibodies in patients recovering from COVID-19 or vaccination.

Features:

●Simple to use, affordable, and self-administered

●Results available within 15 minutes

●Compatible with serum, plasma, whole blood and fingertip blood

●Can be scaled for frequent screening of personal health and population health. 

Clinical Benefits:

●Evaluate COVID-19 vaccines development and efficacy

●Monitor the Neutralization Antibody titers in COVID-19 patients and vaccinated individuals

●Analyze herd immunity status to guide policymakers

●Monitor during convalescent plasma therapy or other antibody related treatments